Scientists in the field of
biochemistry have been told of the "substantial benefits" that mass spectrometry is able to deliver.
Berlin-based Atlas Biolabs explains that mass spectrometry, when used to analyse genetic material, yields very precise quantitative results.
This is in spite of needing only very small quantities of genomic DNA in order to be able to carry out the analysis.
"With the direct detection method it is possible to find even low-frequency mutations, which might otherwise go undetected," the firm advises.
Atlas Biolabs itself provides products for
biochemistry applications and genomic disciplines.
They include the MassARRAY platform for single nucleotide polymorphism (SNP) genotyping, which can process a 384-position array in between 45 and 60 minutes.
With multiplexing capabilities for up to 40 SNPs per reaction, this equates to potential throughput of 150,000 genotypes per day.
Atlas Biolabs' own products aim to be of consistent quality thanks to the company's adherence to stringent internal standards.
Product directory
